首頁 > 市場調查報告書 > 醫療設備

生技設備

微流體市場規模、佔有率和成長分析（按產品、材料、應用、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1900198

微流體市場規模、佔有率和成長分析（按產品、材料、應用、最終用戶和地區分類）－2026-2033年產業預測

Microfluidics Market Size, Share, and Growth Analysis, By Product (Microfluidics-based Device, Microfluidic Components), By Material (Glass, Silicon), By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球微流體市場規模將達到 244.8 億美元，到 2025 年將達到 276.1 億美元，到 2033 年將達到 723.8 億美元，在預測期（2026-2033 年）內，複合年成長率為 12.8%。

微流體裝置利用液體和氣體在微觀尺度上的獨特物理和化學性質，相較於傳統系統具有顯著優勢。這些裝置透過減少所需的樣品、試劑和化學品用量，降低了應用的整體成本。其廣泛的應用領域，包括毛細管電泳、免疫檢測和流式細胞技術，已成為疾病篩檢和癌症早期檢測等過程中不可或缺的工具。慢性病和感染疾病的上升以及人口老化推動了市場成長。此外，製造商和開發商對微流體技術進步的日益關注也促進了行業的擴張。為拓展新市場和提升生產能力所做的共同努力，也推動了微流體解決方案的持續發展和市場需求。

全球微流體市場促進因素

全球微流體市場的成長主要受到微流體技術創新進步的顯著影響，例如晶片實驗室和晶片器官系統。這些先進技術不僅能夠實現快速、精準的診斷流程，還能促進藥物遞送系統的改進，這對個人化醫療、即時檢測和藥物研發至關重要。因此，在醫療保健應用領域對高效能、精準解決方案需求不斷成長的推動下，市場持續擴張。這種發展趨勢標誌著診斷和治療方法的開發與交付方式發生了變革性轉變，也是推動整個市場向前發展的動力。

全球微流體市場限制因素

微流體市場面臨的主要挑戰之一是新興經濟體對此技術的認知度和應用率不足。這些地區的醫療服務提供者往往對微流體技術的優點和應用了解有限，導致其應用緩慢，對創新診斷和治療解決方案的需求不足。這種知識鴻溝阻礙了微流體技術的進步和發展，使其在這些市場的潛在優勢無法充分發揮。因此，對醫療專業人員進行微流體技術價值的教育和培訓至關重要，這有助於提高技術的接受度，並刺激該技術能夠產生重大影響的地區的市場成長。

全球微流體市場趨勢

全球微流體市場正呈現出顯著的發展趨勢，這主要得益於對照護現場（POC）解決方案日益成長的需求，這些解決方案優先考慮快速、準確的診斷。這種轉變正在革新傳統的醫療服務模式，使患者能夠更及時地獲得醫療服務，尤其是在醫療資源匱乏的農村地區。隨著醫療服務提供者尋求透過簡化檢測流程來改善治療效果，微流體設備在急診和居家照護中的應用也日益廣泛。對個人化醫療的關注以及人們對即時檢測優勢的日益重視，進一步加速了微流體技術在各領域的應用。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭格局

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市集活動
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Thermo Fisher Scientific（US）
Becton, Dickinson, and Company（US）
Agilent Technologies（US）
Bio-Rad Laboratories（US）
F. Hoffmann-La Roche（Switzerland）
Danaher Corporation（US）
Illumina Inc.（US）
Fluidigm Corporation（US）
Abbott Laboratories（US）
BioMerieux（France）
Hologic（US）
Quidel Corporation（US）
SMC Corporation（Japan）
Parker-Hannifin Corporation（US）
IDEX Corporation（US）
Fortive Corporation（US）
Aignep SpA（Italy）
Dolomite Microfluidics（UK）
Elveflow（France）
uFluidix（Canada）
NanoString Technologies（US）
Nortis Inc.（US）
Innovative Biochips, LLC（US）
Fluidic Analytics（UK）

結論與建議

簡介目錄

Product Code: SQMIG35A2288

Global Microfluidics Market size was valued at USD 24.48 Billion in 2024 and is poised to grow from USD 27.61 Billion in 2025 to USD 72.38 Billion by 2033, growing at a CAGR of 12.8% during the forecast period (2026-2033).

Microfluidic devices leverage the unique physical and chemical properties of liquids and gases at the microscale, offering significant advantages over traditional systems. These devices reduce overall application costs by requiring smaller volumes of samples, reagents, and chemicals. Their broad applications extend to capillary electrophoresis, immunoassays, flow cytometry, and more, making them vital for processes such as disease screening and early cancer detection. The market is experiencing growth fueled by rising chronic and infectious disease prevalence, coupled with an aging population. Moreover, increasing interest from manufacturers and developers in advancing microfluidic technology is driving industry expansion. Collaborative efforts to penetrate new markets and enhance production capabilities also contribute to the ongoing evolution and demand for microfluidic solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microfluidics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microfluidics Market Segments Analysis

Global Microfluidics Market is segmented by Product, Material, application, end user and region. Based on Product, the market is segmented into Microfluidics-based Device, Microfluidic Components. Based on Material, the market is segmented into Glass, Silicon, Polymer, and Others. Based on Application, the market is segmented into In Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing, Therapeutics. Based on End User, the market is segmented into Hospital and Diagnostic Centers, Academic and Research Institute, Pharmaceutical & Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Microfluidics Market

The growth of the global microfluidics market is significantly influenced by innovative advancements in microfluidic technologies, such as lab-on-a-chip and organ-on-chip systems. These sophisticated technologies facilitate rapid and precise diagnostic processes, along with improved drug delivery systems, which are crucial for personalized medicine, point-of-care testing, and pharmaceutical research. As a result, the market continues to expand, driven by the increasing demand for efficient and accurate solutions in healthcare and medical applications. This evolution represents a transformative shift in how diagnostics and therapeutics are developed and administered, thereby propelling the overall market forward.

Restraints in the Global Microfluidics Market

One of the significant challenges facing the microfluidics market is the lack of awareness and adoption in emerging economies. Healthcare providers in these regions often have limited understanding of the advantages and applications of microfluidic technologies, resulting in slow integration and insufficient demand for innovative diagnostic and treatment solutions. This knowledge gap hinders the progress and growth of microfluidics, as potential benefits remain untapped in these markets. Consequently, efforts to educate and inform healthcare professionals about the value of microfluidics are crucial for fostering acceptance and stimulating market growth in areas where such technologies could have a substantial impact.

Market Trends of the Global Microfluidics Market

The Global Microfluidics market is witnessing a significant trend driven by the increasing demand for point-of-care (POC) testing solutions, which prioritize rapid and accurate diagnostics. This shift enhances patient access to timely care, particularly in underserved and rural areas, thereby revolutionizing traditional healthcare delivery models. The integration of microfluidic devices in both emergency settings and home care is on the rise, as healthcare providers seek to improve outcomes through streamlined testing processes. The focus on personalized medicine and the growing awareness of the advantages of POC diagnostics are further accelerating the adoption of microfluidics technologies across various sectors.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Case studies
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Macro-Economic Indicators
PESTEL Analysis
Top Investment Analysis
Key Success Factor
Degree of Competition

Microfluidics Market by Product & CAGR (2026-2033)

Market Overview
Microfluidics-based Device
Microfluidic Components
- Microfluidic Chip
- Flow And Pressure Sensors
- Flow And Pressure Controllers
- Micropumps
- Microfluidic Valves
- Microneedles
- Other Components

Microfluidics Market by Material & CAGR (2026-2033)

Market Overview
Glass
Silicon
Polymer
Others

Microfluidics Market by Application & CAGR (2026-2033)

Market Overview
In Vitro Diagnostics
- Clinical Diagnostics
- Point of Care Testing
- Veterinary Diagnostics
Pharmaceutical & Life Science Research and Manufacturing
- Lab Analytics
- Proteomic analysis
- Genomic analysis
- Cell-based assays
- Capillary electrophoresis
- Microdispensing
- Microreaction
Therapeutics
- Drug Delivery
- Wearable Devices

Microfluidics Market by End-user & CAGR (2026-2033)

Market Overview
Hospital and Diagnostic Centers
Academic and Research Institute
Pharmaceutical & Biotechnology Companies

Microfluidics Market Size & CAGR (2026-2033)

Market Overview
North America (Product, Material, Application, End User)
- US
- Canada
Europe (Product, Material, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Material, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Material, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Material, Application, End User)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson, and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidigm Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioMerieux (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quidel Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SMC Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Parker-Hannifin Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IDEX Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fortive Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aignep S.p.A (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dolomite Microfluidics (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elveflow (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
uFluidix (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NanoString Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nortis Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Innovative Biochips, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidic Analytics (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments